The Prognostic Value Of Dynamic Monitoring C-Reactive Protein (CRP) Serum Levels In NK/T-Cell Lymphoma
Explore this paper's citation graph
Summary
The study suggests that elevated early-treatment CRP is an independent unfavorable prognostic factor for patients with NK/TCL.
- Type
- article
- Published
- 2013-11-15
- Cited by
- 1
- References
- 0
- OpenAlex
- https://openalex.org/W2470491316
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:77612977
Keywords
Medicine, C-reactive protein, Internal medicine, Gastroenterology, Lymphoma
References
No references recorded for this paper.
Cited by
Related papers
- Experience of Diagnosis and Treatment of Inflammatory Intestinal Obstruction in early Stage
- High Sensitivity C-reactive Protein and Cardiovascular Risk Prediction
- Chemotherapy as definitive treatment of stage I‐II large cell and diffuse mixed lymphomas
- Haemoglobin Epsilon as a Biomarker for the Molecular Detection of Canine Lymphoma
- The therapeutic value of preoperative neoadjuvent chemotherapy in patients with stage Ib2～IIb bulky cervical cancer
- Thyroid disorders in patients with newly diagnosed rheumatoid arthritis is associated with poor initial treatment response evaluated by disease activity score in 28 joints-C-reactive protein (DAS28-CRP)
- Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer.
- Role of chemotherapy in stage IIb nasopharyngeal carcinoma
- Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer